Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion.

@article{Knauf2017LossOC,
  title={Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion.},
  author={Felix Knauf and Robert B Thomson and John F. Heneghan and Zhirong Jiang and Adedotun Adebamiro and Claire L Thomson and Christina Barone and John R. Asplin and Marie E Egan and Seth L Alper and Peter S. Aronson},
  journal={Journal of the American Society of Nephrology : JASN},
  year={2017},
  volume={28 1},
  pages={
          242-249
        }
}
Patients with cystic fibrosis have an increased incidence of hyperoxaluria and calcium oxalate nephrolithiasis. Net intestinal absorption of dietary oxalate results from passive paracellular oxalate absorption as modified by oxalate back secretion mediated by the SLC26A6 oxalate transporter. We used mice deficient in the cystic fibrosis transmembrane conductance regulator gene (Cftr) to test the hypothesis that SLC26A6-mediated oxalate secretion is defective in cystic fibrosis. We mounted… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 6 times. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Subclinical celiac disease and crystal-induced kidney disease following kidney transplant.

American journal of kidney diseases : the official journal of the National Kidney Foundation • 2012

Net intestinal transport of oxalate re fl ects passive absorption and SLC 26 A 6mediated secretion

F Knauf, N Ko, +4 authors PS Aronson
J Am Soc Nephrol • 2011

Oxalate nephropathy associated with chronic pancreatitis.

Clinical journal of the American Society of Nephrology : CJASN • 2011

Similar Papers

Loading similar papers…